Patrick Campbell

An analysis of 2 major studies is comparing the effects of bariatric surgery vs standard medical therapy on risk of cardiovascular disease events in obese teens with type 2 diabetes.

A comparison of data from Teen-LABS and TODAY offer insight into the effects of medical therapy alone vs bariatric surgery in obese teens with type 2 diabetes.

An analysis of data from more than 900k Veterans suggests use of SSRIs in those with PTSD was associated with an increased risk of hemorrhagic stroke.

An analysis of data from Geisinger suggests living closer to fracking activity could increase a person's risk of hospitalization for heart failure.

Results of the INVESTED trial offer clinicians into the effects of high-dose versus standard-dose influenza vaccines in patients with high-risk cardiovascular disease.

An analysis of data from the Look AHEAD study details the associations between long-term variability of glycemic markers and increased risk of all-cause and cardiovascular mortality.

New research from the Mayo Clinic is outlining the successes and pitfalls of efforts to improve statin adherence in a comparison of data from the OptumLab Data Warehouse from 2007-2016.

An analysis of data over a 12-year period details the disparities in outcomes following first heart attack among female versus male patients.

Analysis of 7-year follow-up data from an observational study of severely obese patients details the effects of gastric bypass and gastric banding on long-term diabetes remission.

Data from an analysis of more than 25k women by a team from Brigham and Women's Hospital and Harvard Medical School suggests greater adherence to a Mediterranean diet was linked to a lower risk of developing diabetes.

An analysis of the Look AHEAD study by investigators at Johns Hopkins details associations between long-term variability of glycemic markers and increased risk of all-cause and cardiovascular mortality.

Data from more than 37k patients in the UK Biobank study suggests hypertension in midlife was linked to an increased risk of white matter hyperintensities later in life.

A recent analysis of more than 45k patients from Canada suggests women were 20% more likely to die or develop heart failure in the first 5 years after an incident myocardial infarction.

An analysis of data from more than 25k women suggests greater adherence to a Mediterranean diet was linked to a lower risk of developing diabetes.

An analysis of data from the Women's Health Initiative suggests spending more than 6.5 hours engaged in sedentary behaviors each day was linked to a 42% increase in risk of heart failure in older women.

In this 3-part feature series, an endocrinologist, a cardiologist, and an internist tackle the topic of who should be in charge of treating patients with diabetes and whether the creation of a cardiometabolic specialty is a worthwhile endeavor.

In this 3-part feature series, an endocrinologist, a cardiologist, and an internist tackle the topic of who should be in charge of treating patients with diabetes and whether the creation of a cardiometabolic specialty is a worthwhile endeavor.

An analysis of data from the Women's Health Initiative details the detrimental impact of sedentary behavior on the risk of heart failure in older women.

Researchers present new data from the SUSTAIN 6 and PIONEER 6 trials during the virtual AHA 2020 conference.

An analysis of data from a pair of major trials indicates use of semaglutide was associated with a reduction in MACE regardless of a patient's baseline triglyceride levels.

An analysis of cardiovascular outcomes from FIDELIO-DKD suggest finerenone use was associated with a 14% reduction in negative cardiovascular outcomes.

A cardiologist from Brigham and Women's Hospital offers his thoughts on the results of phase 3 SCORED and SOLOIST trials, which examined use of sotagliflozin in patients with type 2 diabetes.

An analysis of CDC data presented at AHA Scientific Sessions 2020 suggests rates of high blood pressure complications among pregnant women nearly doubled during a period lasting from 2008-2017.

An analysis from AHA 2020 suggests an HbA1c screening protocol doubled the proportion of patients with known dysglycemia when treating patients with ST-elevation myocardial infarction.

A cardiologist from Brigham and Women's Hospital offers his thoughts on the results of phase 3 SCORED and SOLOIST trials, which examined use of sotagliflozin in patients with type 2 diabetes.

TRANSLATE-HF is a collaborative effort between the AHA and AstraZeneca with the goal of increasing and optimizing SGLT2 inhibitor use in US patients. Hear further insight lead author from the first of 6 TRANSLATE-HF studies, which was presented at AHA 2020.

George Bakris, MD, discusses a study he took part in from AHA 2020 examining the number of diabetic patients meeting the American Diabetes Association's criteria for prescribing an SGLT2 inhibitor.

Deepak Bhatt, MD, MPH, offers his thoughts on the most important REDUCE-IT analyses released in 2020 and why he disagrees with the notion results of the STRENGTH trial somehow impact the use of icosapent ethyl in clinical settings.

Deepak Bhatt, MD, MPH, offers his thoughts on the results of SCORED and SOLOIST as well as diving deeper into the implications of the data for sotagliflozin and SGLT2 inhibitors moving forward.

Data from a pair of phase 3 trials detail the effects of sotagliflozin in patients with type 2 diabetes and other comorbidities, such as worsening heart failure and chronic kidney disease.